title: Systemic treatment with protein synthesis inhibitors attenuates the expression of cocaine memory.
abstract: It has been proposed that a memory trace enters a labile phase each time it is retrieved. A reactivated memory relies on de novo protein synthesis to be faithfully reconsolidated and restored. Thus, in theory, a long-lasting and pathological memory associated with drug use may be disrupted by inhibiting its reconsolidation through use of protein synthesis inhibitors administered immediately following the memory retrieval. However, effective and efficient strategies to reactivate drug memory remained elusive. This study was undertaken to examine the effects of systemic cycloheximide and anisomycin treatment on the reconsolidation and maintenance of a reactivated cocaine-conditioned place preference (CPP) in mice using several strategies designed to reactivate the previously acquired memory. We found that anisomycin (50 mg/kg/injection) and cycloheximide (15 mg/kg/injection) administered immediately after the reactivation of cocaine-CPP ameliorated subsequent expression and maintenance of this memory. Likewise, when anisomycin and cycloheximide were administered immediately after additional cocaine and saline conditioning trials, the reactivated memory engendered by those extra training trials was also diminished. However, a similar anisomycin dosing regimen failed to affect subsequent expression of cocaine-CPP when additional cocaine conditioning trial was used in the absence of additional saline trial. Finally, cocaine and saline administration to mice in their home cages with or without anisomycin treatment had no effect on later cocaine-CPP expression. Taken together, these findings suggest that systemic treatment with protein synthesis inhibitors immediately after the reactivation of cocaine-CPP effectively diminished the reconsolidation and maintenance of such a cocaine memory. More importantly, reactivation of cocaine-CPP could be achieved by presentation of cocaine-conditioned cues as well as by administering additional cocaine and saline conditioning trials in a balanced fashion.
authors.affiliation: Institute of Behavioral Medicine, National Cheng Kung University College of Medicine, Tainan, Taiwan, ROC.
authors.forename: Hsin-Yi
authors.initials: HY
authors.lastname: Fan
authors.forename: Chianfang G
authors.initials: CG
authors.lastname: Cherng
authors.forename: Fu-Yung
authors.initials: FY
authors.lastname: Yang
authors.forename: Ling-Yi
authors.initials: LY
authors.lastname: Cheng
authors.forename: Chia-Jung
authors.initials: CJ
authors.lastname: Tsai
authors.forename: Li-Ching
authors.initials: LC
authors.lastname: Lin
authors.forename: Lung
authors.initials: L
authors.lastname: Yu
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D000841:Anisomycin / Q000494:pharmacology*; D003042:Cocaine / Q000008:administration & dosage / Q000494:pharmacology*; D003213:Conditioning, Psychological / Q000187:drug effects; D003513:Cycloheximide / Q000494:pharmacology*; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D004334:Drug Administration Schedule; D004347:Drug Interactions; D008297:Male; D008568:Memory / Q000187:drug effects*; D051379:Mice; D008810:Mice, Inbred C57BL; D009043:Motor Activity / Q000187:drug effects; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology*
chemical_list: D018765:Dopamine Uptake Inhibitors; D011500:Protein Synthesis Inhibitors; D000841:Anisomycin; D003513:Cycloheximide; D003042:Cocaine